WeightWatchers is buying digital health company Sequence to capitalize on the hot market for diabetes and weight loss drugs including Ozempic and Wegovy. WSJ's Andrea Petersen explains what this could mean for the wellness industry.
-WeightWatchers Moves Into the Ozempic Market With Telehealth Deal
-How a Diabetes Drug Became the Talk of Hollywood, Tech and the Hamptons
-Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight
While campaigning for president, Joe Biden said there would be no new oil drilling on federal land. But last week he approved the Willow project, one of the largest domestic oil projects in years. WSJ’s Andrew Restuccia explains why Biden made the shift.
TikTok CEO Shou Zi Chew is due to testify before Congress this week, as the Biden administration demands that TikTok’s Chinese owners sell their stakes in the company or face a possible U.S. ban of the app. In this exclusive interview with WSJ’s Stu Woo, the TikTok CEO said a sale won’t solve Washington’s security concerns.
Google has been a pioneer in the modern era of artificial intelligence, but lately, it’s fallen behind. WSJ’s Miles Kruppa explains why the tech giant took a more cautious approach to chatbots and what’s at stake now that Microsoft has beaten them to market.